GeneDx Retained Earnings from 2010 to 2025

WGS Stock

99.13 3.28 3.42%

GeneDx Holdings Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that GeneDx Holdings Corp retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2010-12-31

Previous Quarter

-1.4 B

Current Value

-1.3 B

Quarterly Volatility

517.5 M

Credit Downgrade

Yuan Drop

Covid

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 30.9 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.

Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of GeneDx Holdings Corp over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. GeneDx Holdings' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (1.35 B)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

GeneDx Retained Earnings Regression Statistics

	Arithmetic Mean	(428,408,456)
	Geometric Mean	210,234,784
	Coefficient Of Variation	(120.80)
	Mean Deviation	436,916,502
	Median	(88,711,000)
	Standard Deviation	517,497,773
	Sample Variance	267803.9T
	Range	1.3B
	R-Value	(0.83)
	Mean Square Error	87428.6T
	R-Squared	0.70
	Significance	0.00006
	Slope	(90,635,964)
	Total Sum of Squares	4017059.2T

GeneDx Retained Earnings History

	2025	-1.3 B
	2024	-1.4 B
	2023	-1.3 B
	2022	-1.1 B
	2021	-575.4 M
	2020	-330.1 M

Other Fundumenentals of GeneDx Holdings Corp

Retained Earnings Total Equity

GeneDx Holdings Retained Earnings component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Deferred Long Term Liab	Total Current Assets	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Long Term Debt	Total Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Common Stock	Long Term Debt Total	Capital Surpluse	Intangible Assets
Net Tangible Assets		-0.82	0.19	0.63	0.64	0.6	0.73	0.94	0.95	-0.92	-0.26	0.37	-0.95	0.95	0.2	0.55	-0.09	-0.47	-0.51	-0.51	-0.59
Retained Earnings	-0.82		0.01	-0.9	-0.83	-0.24	-0.95	-0.86	-0.89	0.97	-0.17	-0.61	0.92	-0.9	0.1	-0.19	0.0	0.63	0.62	0.62	0.75
Accounts Payable	0.19	0.01		0.24	0.34	0.65	0.15	0.36	0.31	-0.14	-0.67	-0.68	-0.23	0.28	0.97	0.43	0.54	0.68	0.41	0.41	0.47
Net Receivables	0.63	-0.9	0.24		0.87	0.19	0.93	0.75	0.78	-0.86	0.17	0.34	-0.8	0.78	0.11	0.04	0.31	-0.32	-0.49	-0.49	-0.56
Deferred Long Term Liab	0.64	-0.83	0.34	0.87		0.49	0.95	0.8	0.84	-0.82	-0.15	0.4	-0.84	0.84	0.19	0.41	-0.01	-0.37	-0.3	-0.3	-0.41
Total Current Assets	0.6	-0.24	0.65	0.19	0.49		0.31	0.67	0.64	-0.42	-0.91	-0.19	-0.59	0.62	0.64	0.96	-0.22	0.04	0.0	0.0	0.01
Property Plant Equipment	0.73	-0.95	0.15	0.93	0.95	0.31		0.81	0.87	-0.91	0.08	0.56	-0.88	0.88	0.02	0.23	0.04	-0.5	-0.44	-0.44	-0.57
Total Assets	0.94	-0.86	0.36	0.75	0.8	0.67	0.81		0.99	-0.95	-0.32	0.28	-0.97	0.98	0.31	0.59	0.0	-0.39	-0.44	-0.44	-0.53
Total Stockholder Equity	0.95	-0.89	0.31	0.78	0.84	0.64	0.87	0.99		-0.96	-0.28	0.37	-0.99	1.0	0.26	0.57	-0.03	-0.43	-0.44	-0.44	-0.54
Current Deferred Revenue	-0.92	0.97	-0.14	-0.86	-0.82	-0.42	-0.91	-0.95	-0.96		0.02	-0.49	0.98	-0.97	-0.08	-0.35	-0.02	0.54	0.57	0.57	0.68
Net Debt	-0.26	-0.17	-0.67	0.17	-0.15	-0.91	0.08	-0.32	-0.28	0.02		0.48	0.22	-0.25	-0.71	-0.89	0.2	-0.32	-0.22	-0.22	-0.3
Long Term Debt	0.37	-0.61	-0.68	0.34	0.4	-0.19	0.56	0.28	0.37	-0.49	0.48		-0.43	0.41	-0.74	-0.04	-0.54	-0.92	-0.45	-0.45	-0.64
Total Liab	-0.95	0.92	-0.23	-0.8	-0.84	-0.59	-0.88	-0.97	-0.99	0.98	0.22	-0.43		-1.0	-0.18	-0.53	0.07	0.5	0.53	0.53	0.62
Net Invested Capital	0.95	-0.9	0.28	0.78	0.84	0.62	0.88	0.98	1.0	-0.97	-0.25	0.41	-1.0		0.22	0.55	-0.05	-0.46	-0.46	-0.46	-0.56
Short Long Term Debt	0.2	0.1	0.97	0.11	0.19	0.64	0.02	0.31	0.26	-0.08	-0.71	-0.74	-0.18	0.22		0.44	0.54	0.74	0.44	0.44	0.52
Net Working Capital	0.55	-0.19	0.43	0.04	0.41	0.96	0.23	0.59	0.57	-0.35	-0.89	-0.04	-0.53	0.55	0.44		-0.47	-0.13	-0.07	-0.07	-0.07
Short Term Debt	-0.09	0.0	0.54	0.31	-0.01	-0.22	0.04	0.0	-0.03	-0.02	0.2	-0.54	0.07	-0.05	0.54	-0.47		0.67	0.28	0.28	0.34
Common Stock	-0.47	0.63	0.68	-0.32	-0.37	0.04	-0.5	-0.39	-0.43	0.54	-0.32	-0.92	0.5	-0.46	0.74	-0.13	0.67		0.7	0.7	0.83
Long Term Debt Total	-0.51	0.62	0.41	-0.49	-0.3	0.0	-0.44	-0.44	-0.44	0.57	-0.22	-0.45	0.53	-0.46	0.44	-0.07	0.28	0.7		1.0	0.97
Capital Surpluse	-0.51	0.62	0.41	-0.49	-0.3	0.0	-0.44	-0.44	-0.44	0.57	-0.22	-0.45	0.53	-0.46	0.44	-0.07	0.28	0.7	1.0		0.97
Intangible Assets	-0.59	0.75	0.47	-0.56	-0.41	0.01	-0.57	-0.53	-0.54	0.68	-0.3	-0.64	0.62	-0.56	0.52	-0.07	0.34	0.83	0.97	0.97

Click cells to compare fundamentals

About GeneDx Holdings Financial Statements

GeneDx Holdings shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although GeneDx Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in GeneDx Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneDx Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-1.4 B	-1.3 B
Retained Earnings Total Equity	-1 B	-1.1 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC